These 3 scientific developments could help combat the coronavirus pandemic

Scientists remain hard at work in their efforts to combat the novel coronavirus pandemic and help alleviate the stress on health care systems.
At Stanford University, researchers are hoping to integrate already-on-the-market artificial intelligence called the Deterioration Index that can help doctors predict which coronavirus patients may need escalated care, thus allowing health care workers to spend less time analyzing charts and make treatment decisions more quickly, Stat News reports.
The AI analyzes vital signs, lab test results, medications, and medical history, then rates on a scale of 0 to 100 how high the risk is that a patient's condition deteriorates. The model is used in nearly 50 health systems already, but Stanford wants to make sure it works accurately for COVID-19 patients, as well, since it's a new disease the system wasn't intended to analyze.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In other news, two U.S. companies — BD and BioMedomics — launched a rapid antibody test that can detect if a person has present or past exposure to COVID-19 in as little as 15 minutes. Antibody tests could prove key for better understanding how widespread the pandemic is, and at what stage the world is at, because current coronavirus tests can't determine if a person has already recovered. Most importantly, they could help determine whether some health care workers can treat patients without concern of contracting the virus themselves, as well as allow some people who may have already built up immunity to return to their normal lives.
That doesn't mean firms are halting production of normal diagnostic tests, of course. The Boston Globe reports that researchers from Harvard University and the Massachusetts Institute of Technology are are working on a test that can deliver results in less than 15 minutes, which will hopefully add to the growing number of point-of-care tests hitting the market.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The Week Unwrapped: Why are sinkholes becoming more common?
Podcast Plus, will Saudi investment help create the "Netflix of sport"? And why has New Zealand's new tourism campaign met with a savage reception?
By The Week UK Published
-
How Poland became Europe's military power
The Explainer Warsaw has made its armed forces a priority as it looks to protect its borders and stay close to the US
By Elizabeth Carr-Ellis, The Week UK Published
-
Quiz of The Week: 15 - 21 February
Have you been paying attention to The Week's news?
By The Week Staff Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published